Royalty Pharma PLC (RPRX)

NASDAQ · Pharmaceuticals

59.82
+0.37 (+0.62%)
Updated Aug 18, 6:53 PM ET
AI Rating
Buy
Overall Score
63
Trend
72
Momentum
42
Risk
79

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Feb 24, 2026 120 sessions Aug 14, 2026

AI Analysis

Royalty Pharma PLC is trading at $59.82, up 0.62% on the session. The 50 day average sits at $56.82 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 55, which reads as neutral, and MACD is bearish crossover. Volume is below average.

The nearest support is around $56.53 with resistance near $58.84, so that band frames the current range. Average daily movement is roughly $1.40, or about 2.3% of the share price, which is what any stop placement has to allow for. The overall health score of 63 out of 100 combines a trend score of 72, momentum of 42 and a risk score of 79.

Technical indicators

RSI (14)
55.0
neutral
MACD
0.402
bearish crossover
SMA 20
58.31
SMA 50
56.82
SMA 200
--
unknown
ATR (14)
1.40
avg daily range
Support
56.53
Resistance
58.84
Volume vs 20d
0.55x
below average
Volatility
20.7%
annualised
1 month
+0.12%
3 months
+9.74%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.